Skip to main content
. 2004 Dec 23;563(Pt 3):821–829. doi: 10.1113/jphysiol.2004.080705

Figure 4. Differential effect of the KATP channel opener cromakalim to inhibit the smRLC phosphorylation response to activation of α2- and α1-adrenoceptors.

Figure 4

Cromakalim inhibited the increases in smRLC phosphorylation induced by UK 14,304 (20 μm), but not by phenylephrine (10 μm). Results were similar for soleus and EDL muscles. *P < 0.05 versus no drug; n≥ 4 muscles per treatment.